IndieBio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • IndieBio's estimated annual revenue is currently $9.3M per year.(i)
  • IndieBio's estimated revenue per employee is $155,000

Employee Data

  • IndieBio has 60 Employees.(i)
  • IndieBio grew their employee count by 9% last year.

IndieBio's People

NameTitleEmail/Phone
1
Managing Director and Founder. General PartnerReveal Email/Phone
2
scientific Director & partnerReveal Email/Phone
3
principalReveal Email/Phone
4
program dir & partnerReveal Email/Phone
5
strategy dirReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is IndieBio?

We are the world's leading biotech accelerator, we fund and accelerate 30 biotech startups per year. - We provide global scientists and entrepreneurs with a $250k package that includes a lab and co-working space in down town SF

keywords:N/A

N/A

Total Funding

60

Number of Employees

$9.3M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

IndieBio News

2022-04-19 - IndieBio Startup CellCrine is Developing Serum-Free Growth ...

One of these companies is CellCrine, which claims to be developing the world's cheapest serum-free growth media. As a member of IndieBio's 12th...

2022-04-13 - IndieBio to Demo Day virtually on April 26

In California, IndieBio San Francisco's 12th batch is debuting on April 26 at 10 am PST (virtual). The presentation will be less than 45...

2022-03-22 - SOSV and JetBlue Technology Ventures talk VC climate tech and ESG at TC Sessions: Climate 2022

At both SOSV and IndieBio, Wu is responsible for portfolio management and technical oversight. She's focused on funding early-stage climate...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M60-30%N/A
#2
$6.5M605%N/A
#3
$13.1M60-12%N/A
#4
$7.8M609%N/A
#5
$6.8M60-19%$10M